1 / 3

Global Histology and Cytology Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

The global histology and cytology market is estimated to grow at a significant CAGR of nearly 13.0% during the forecast period.

nabeelomr
Download Presentation

Global Histology and Cytology Market Trends, Size, Competitive Analysis and Forecast - 2019-2025

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. The global histology and cytology market is estimated to grow at a significant CAGR of nearly 13.0% during the forecast period. Rising prevalence of cancer and infectious diseases have led the demand for innovations in the anatomical pathology solutions for more accurate screening and diagnosis of the condition. As a result, several companies are focusing on strategic initiatives such as mergers and acquisitions, product launches, and partnerships and collaborations to expand the range of product portfolio with innovative features that can support to increase their market share. Some key players operating in the market include Abbott Laboratories, Merck KGaA, F. Hoffman-La Roche AG, Hologic, Inc., and Becton, Dickinson, and Co. They are increasing capabilities of their histology and cytology tests to deliver complete automation, faster turnaround time, and increased throughput that will offer users with considerable flexibility to increase overall workflow efficiencies. Some crucial strategic initiatives by the market players include- Get Free Sample Copy @ https://www.omrglobal.com/request-sample/histology-and- cytology-market •In March 2020, F. Hoffmann-La Roche Ltd declared the US FDA approval of CINtec PLUS Cytology. It is the first biomarker-based triage test for women whose primary results of cervical cancer screening are positive for the human papillomavirus (HPV) using cobas 4800 HPV Test. It can more facilitate clinical decisions by offering easy to understand results that will support clinicians and women to take further steps. Browse for Full Report at: https://www.omrglobal.com/industry-reports/histology-and- cytology-market The Roche cobas 4800 HPV Test, used along with CINtec histology and CINtec PLUS cytology that can offer powerful support to the labs and clinicians in the US. The CINtec PLUS cytology test features dual-stain biomarker technology that enables to detect the simultaneous presence of the two biomarkers within a single cell, including Ki-67 and p16, which is linked with HPV infections. As a result, the test holds the ability to differentiate those women who are at considerable risk for cervical disease. •In June 2019, PHC Holdings Corp. acquired Anatomical Pathology business from Thermo Fisher Scientific Inc., for nearly $1.1billion. Anatomical Pathology business of Thermo Fisher Scientific is a part of Specialty Diagnostics division, which includes instruments, consumables, and microscope slides. The portfolio covers consumables and laboratory

  2. equipment for rabbit monoclonal antibodies, histology and cytology testing, digital pathology products, and other pathology instruments. With the acquisition of Thermo Fisher’s Anatomical Pathology business,a new stand-alone company named Epredia was established to serve comprehensive anatomical pathology solutions. This acquisition will enable to strengthen the diagnostics business of PHC Holdings Corp. by enhancing the cancer product portfolio and will leverage further growth of the business. •In September 2018, Koninklijke Philips N.V. declared the release of Tissue Mark, a computational pathology software which is intended for the region of interest detection for a large number of molecular testing. This will support research laboratories to improve tumor estimation accuracy. Apart from offering tumor sufficiency guidance for lung cytology, lung histology, and tissue samples of colon and breast in 60 seconds, the updated Tissue Mark software will offer this guidance to high-grade serous carcinoma ovarian tissue and whole slide images (WSI) of adenocarcinoma prostate tissue. This update will allow Tissue Mark to exhibit a wide-ranging portfolio of AI-powered applications. The software will leverage deep learning AI to support in the identification of prostate and ovarian tumor tissues. Global Histology and Cytology Market- Segmentation By Type of Examination •Histology •Cytology By Product •Reagents and Consumables •Instruments and Analysis Software System By End-User •Hospitals and Clinical Laboratories •Academic and Research Institutes Global Histology and Cytology Market– Segment by Region North America •US •Canada Europe

  3. •Germany •UK •France •Spain •Italy •Rest of Europe Asia-Pacific •China •Japan •India •Rest of Asia-Pacific Rest of the World •Latin America •Middle East and Africa For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/histology-and-cytology-market About Orion Market Research Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research- based services. Media Contact: Company Name: Orion Market Research Contact Person: Mr. Anurag Tiwari Email: info@omrglobal.com Contact no: +91 780-304-0404

More Related